AJP - GI Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 289: G181-G187, 2005. First published February 10, 2005; doi:10.1152/ajpgi.00297.2004
0193-1857/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/2/G181    most recent
00297.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Keefe, S. J. D.
Right arrow Articles by Zhou, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Keefe, S. J. D.
Right arrow Articles by Zhou, W.

TRANSLATIONAL PHYSIOLOGY

Trypsin secretion and turnover in patients with acute pancreatitis

Stephen J. D. O'Keefe,1,2 Ronzo B. Lee,1 Jing Li,1 Stacie Stevens,1 Souheil Abou-Assi,1 and Wen Zhou2

1Division of Gastroenterology, Virginia Commonwealth University Health Systems, Richmond, Virginia; and 2University of Pittsburgh Medical School, Pittsburgh, Pennsylvania

Submitted 8 July 2004 ; accepted in final form 3 January 2005

ABSTRACT

Studies in humans have shown that pancreatic enzyme secretion is reduced during acute pancreatitis. It is not known, however, whether the reduction is due to impaired synthesis or disruption of the secretory pathway. The rate of secretion and turnover of trypsin was measured in 12 patients with acute pancreatitis of variable etiology and severity (median Ranson's score 2.5, range 0–5, 4 with severe necrotizing disease) and eight healthy volunteers by 4-h primed/continuous intravenous infusions of 1-13C-labeled L-leucine, and collection of pancreatic secretions by duodenal perfusion and sampling. Trypsin secretion was reduced from 476 ± 73 to 153 ± 60 U/h (means ± SE, P = 0.005) in acute pancreatitis, with the greatest reductions being observed in patients with necrotizing disease (32 ± 7 U/h, P = 0.003). The time for newly labeled trypsin to first appear in digestive juice was not, however, delayed in pancreatitis patients (87.2 ± 11.1 vs. 94.7 ± 4.9 min); on the contrary, there was an early appearance of newly labeled trypsin at 30 min in patients with severe necrotizing pancreatitis (P < 0.05). Calculated zymogen pool turnover was unchanged, but pool size was decreased (P = 0.01). Despite low rates of luminal secretion, trypsin continues to be synthesized in patients with acute pancreatitis. Our findings could be explained by post-Golgi leakage of enzymes from acinar cells or by loss of synthetic function in some cells with preservation in others.



Address for reprint requests and other correspondence: S. J. D. O'Keefe, Division of Gastroenterology, Univ. of Pittsburgh Medical School, Pittsburgh, PA 15213 (E-mail: sjokeefe{at}pitt.edu)




This article has been cited by other articles:


Home page
GutHome page
V. P Singh, L. Bhagat, S. Navina, R. Sharif, R. K Dawra, and A. K Saluja
Protease-activated receptor-2 protects against pancreatitis by stimulating exocrine secretion
Gut, July 1, 2007; 56(7): 958 - 964.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.